Results 171 to 180 of about 16,748,637 (363)
Pathogenesis of Vitiligo: Integrating Immune and Non‐Immune Cell Crosstalk
ABSTRACT Vitiligo is an acquired autoimmune disease characterized by depigmented macules resulting from melanocyte loss. It is a complex multifactorial disorder in which genetic predisposition is combined with environmental factors; however, its detailed etiology remains unclear.
Shintaro Inoue
wiley +1 more source
Isozymes of cyclic-3′,5′-nucleotide phosphodiesterases in renal epithelial LLC-PK1 cells
Mark E. Rassier +5 more
openalex +1 more source
ABSTRACT Atopic dermatitis (AD) is a chronic, itchy skin disease that often begins in infancy and may persist into adulthood. The high co‐occurrence of allergic comorbidities (ACMs; asthma, food allergy, and allergic rhinitis) makes it a growing public health concern.
Masaki Futamura +6 more
wiley +1 more source
K-134, a phosphodiesterase 3 inhibitor, reduces vascular inflammation and hypoxia, and prevents rupture of experimental abdominal aortic aneurysms. [PDF]
Unno N +9 more
europepmc +1 more source
Determination of 2-Aryl-7(3',4'-Dialkoxyphenyl)-Pyrazolo [1,5-alpha] Pyrimidine, a Novel Phosphodiesterase-4 Inhibitor, in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry [PDF]
K. R. Lee +7 more
openalex +1 more source
Abstract Aims This study sought to validate a community‐acceptable Substance Use & Sex Index (SUSI) for use in substance use intervention research. SUSI aims to measure behaviours associated with the transmission of blood‐borne viruses (BBV) and sexually transmitted infections (STI) among people who use substances and incorporate contemporary sexual ...
Brendan Clifford +9 more
wiley +1 more source
Muhammad Asad Faruqi,1 Malik M Khurram S Khan,1 David M Mannino1,2 1University of Kentucky College of Medicine, Lexington, KY, USA; 2COPD Foundation, Miami, FL, USACorrespondence: David M Mannino, Department of Medicine, University of Kentucky College of
Faruqi MA, Khan MMKS, Mannino DM
doaj
Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis. [PDF]
Watz H +4 more
europepmc +1 more source

